Showing 1 - 4 results of 4 for search 'Maryia Zhdanava', query time: 0.02s Refine Results
  1. 1
    Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

    Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R. Feldman

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

    Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R. Feldman

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis

    Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analys... by Geneviève Gauthier, Annie Guérin, Maryia Zhdanava, William Jacobson, George Nomikos, Elizabeth Merikle, Clément François, Vanessa Perez

    Published 2017-06-01
    Get full text
    Article
  4. 4
    Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab

    Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab by Abhishek Kavati, Dominic Pilon, Benjamin Ortiz, Brandee Paknis, Ashok Vegesna, Bradd Schiffman, Maryia Zhdanava, Patrick Lefebvre, Brian Stone

    Published 2018-04-01
    Get full text
    Article

Search Tools: